60 Day FRN

48146

Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name

Health care providers ......................................

Study screener ...............................................
Web-based survey .........................................
Exploratory Guide—Prevention with Positives
In-depth Interview.
Exploratory Guide—Patient Centered Care
In-depth Interview.
Exploratory Guide—HIV Prevention In-depth
Interview.
Message Testing In-depth Interview Guide ...
Concept Testing In-depth Interview Guide ....
Materials Testing In-depth Interview ..............

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–18540 Filed 8–26–21; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0600; Docket No. CDC–2021–
0087]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).

AGENCY:

ACTION:

Notice with comment period.

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled CDC Model Performance
Evaluation Program (MPEP) for
Mycobacterium tuberculosis
Susceptibility Testing information
collection. CDC is requesting a threeyear approval for revision to the
previously approved project used to
monitor and evaluate performances and
practices among national laboratories
for M. tuberculosis susceptibility
testing.

SUMMARY:

lotter on DSK11XQN23PROD with NOTICES1

Number of
respondents

Type of respondent

VerDate Sep<11>2014

17:52 Aug 26, 2021

Jkt 253001

CDC must receive written
comments on or before October 26,
2021.

DATES:

You may submit comments,
identified by Docket No. CDC–2021–
0087 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
ADDRESSES:

PO 00000

Frm 00033

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

Average
burden per
response
(in hours)

1,138
569
95

1
1
1

10/60
15/60
1

95

1

1

95

1

1

95
95
95

1
1
1

1
1
1

collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium
tuberculosis Susceptibility testing (OMB
Control No. 0920–0600, Exp. 2/20/
2022)—Revision—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is requesting a
revision to approved information
collection from participants in the CDC
Model Performance for Mycobacterium
tuberculosis Drug Susceptibility Testing
Program for a period of three years.
Revision of this information will not

E:\FR\FM\27AUN1.SGM

27AUN1

48147

Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices

Participants in this program include
domestic clinical and public health
laboratories. Data collection from
laboratory participants occurs twice per
year. The data collected in this program
will include the susceptibility test
results of primary and secondary drugs,
drug concentrations, and test methods
performed by laboratories on a set of
performance evaluation (PE) isolates.
The PE isolates are sent to participants
twice a year, and participants also
report demographic data such as
laboratory type and the number of drug
susceptibility tests performed annually.
CDC requests approval for an
estimated 129 burden hours annually.
There is no cost to respondents to
participate other than their time.

for Mycobacterium tuberculosis
susceptibility testing is used to monitor
and evaluate performance and practices
among US laboratories performing M.
tuberculosis susceptibility testing.
Participation in this program is one way
laboratories can ensure high-quality
laboratory testing, resulting in accurate
and reliable testing results.
By providing an evaluation program
to assess the ability of laboratories to
test for drug resistant M. tuberculosis
strains, CDC gives laboratories a selfassessment tool to aid in optimizing
their skills in susceptibility testing. The
information obtained from the
laboratories on susceptibility practices
and procedures is used to establish
variables related to good performance,
assess training needs, and aid with the
development of practice standards.

require changes in the scope of the
project. This Revision includes; (a)
modification of the Instructions to
Participants Letter; (b) modification of
the MPEP Mycobacterium tuberculosis
Results Worksheet; (c) modification of
online data collection instrument; (d)
modification of the MPEP
Mycobacterium tuberculosis Minimum
Inhibitory Concentration Results
Worksheet; (e) removal of Reminder
Telephone Script; and (f) modification
of Aggregate Report Letter.
While the overall number of cases of
TB in the U.S. has decreased, rates still
remain high among foreign-born
persons, corrections, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
To reach the goal of eliminating TB, the
Model Performance Evaluation Program

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

Domestic Laboratory .....

Participant Biosafety Compliance Letter of
Agreement.
MPEP Mycobacterium tuberculosis Results
Worksheet.
Online Survey Instrument ....................................
MPEP Mycobacterium tuberculosis Minimum Inhibitory Concentration Results Form.

Total ........................

..............................................................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–18541 Filed 8–26–21; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics
(BSC, NCHS)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).

AGENCY:

lotter on DSK11XQN23PROD with NOTICES1

ACTION:

Notice of meeting.

In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Health Statistics
BSC, NCHS). This meeting is open to
the public.

SUMMARY:

VerDate Sep<11>2014

17:52 Aug 26, 2021

Jkt 253001

Number of
responses per
respondent

Number of
respondents

Type of respondents

1

5/60

7

80

2

30/60

80

80
4

2
2

15/60
15/60

40
2

........................

........................

........................

129

The meeting will be held on
October 22, 2021, from 11:00 a.m. to
5:30 p.m., EDT.
ADDRESSES: Instructions to access the
meeting are posted on the BSC website:
https://www.cdc.gov/nchs/about/bsc/
bsc_meetings.htm.
FOR FURTHER INFORMATION CONTACT:
Rebecca Hines, M.H.S., Executive
Secretary, NCHS/CDC, Board of
Scientific Counselors, 3311 Toledo
Road, Room 2627, Hyattsville, Maryland
20782, Telephone: (301) 458–4717;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Board is charged with
providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters To Be Considered: The
meeting agenda includes welcome
remarks and a Center update by the
NCHS Director; updates on Data
Modernization (DMI), including
Epidemiology and Laboratory Capacity

Frm 00034

Fmt 4703

Total burden
(in hours)

80

DATES:

PO 00000

Average
burden per
response
(in hours)

Sfmt 4703

for Prevention and Control of Emerging
Infectious Diseases (ELC) Collaboration;
an update on the National Center for
Health Statistics Strategic Planning;
presentation on the NCHS Health Equity
Strategy; updates on using the National
Health Interview Survey (NHIS) as a
platform for additional data collection;
and an update on several NCHS
Programs. Agenda items are subject to
change as priorities dictate.
Meeting Information: Please visit the
BSC website: https://www.cdc.gov/nchs/
about/bsc/bsc_meetings.htm for more
information on the meeting agenda,
including instructions for accessing the
live meeting broadcast.
The Board will reserve time for public
comment at the end of the day.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and

E:\FR\FM\27AUN1.SGM

27AUN1